Navigation Links
Survival Data Available From Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer

tion therapy should be used with caution in patients with known coronary artery disease, congestive heart failure and arrhythmias. Close monitoring of serum electrolytes, including serum magnesium, potassium, and calcium during and after ERBITUX therapy is recommended.

Severe cases of interstitial lung disease (ILD), which was fatal in one case, occurred in less than 0.5% of 774 patients with advanced colorectal cancer (mCRC) receiving ERBITUX. There was one case of ILD reported in 796 patients with head and neck cancer receiving ERBITUX in clinical studies.

In clinical studies of ERBITUX, dermatologic toxicities, including acneform rash, skin drying and fissuring, and inflammatory and infectious sequelae (eg, blepharitis, cheilitis, cellulitis, cyst) were reported. In 208 patients receiving ERBITUX + RT, acneform rash was reported in 87% (17% severe) as compared to 10% in 212 patients treated with radiation therapy alone (1% severe). In patients receiving ERBITUX alone, 76% (N=103) experienced acneform rash (1% severe). In patients with mCRC, acneform rash was reported in 89% (686/774) of all treated patients, and was severe in 11% (84/774). Subsequent to the development of severe dermatologic toxicities, complications including S. aureus sepsis and abscesses requiring incision and drainage were reported. Sun exposure may exacerbate these effects. A related nail disorder, occurring in 12% (0.4% Grade 3) of patients, was characterized as a paronychial inflammation.

The safety of ERBITUX in combination with radiation therapy and cisplatin has not been established. Death and serious cardiotoxicity were observed in a single-am trial with ERBITUX, delayed, accelerated (concomitant boost) fractionation radiation therapy, and cisplatin (100 mg/m2) conducted in patients with locally advanced squamous cell carcinoma of the head and neck. Two of 21 patients died, one as a result of pneumonia and one of an unknown cause. Four patients discontinued treatme
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
7. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
(Date:12/16/2009)... Dec. 16 Boston Scientific Corporation (NYSE: ... of Directors has elected Nelda Connors as a Director. ... the Electrical and Metal Products division of Tyco International. ... Corporation, holding several positions in operations and general management. ... a number of executive and management capacities with Ford, ...
(Date:12/16/2009)... According to Millennium Research Group (MRG), the global ... reforms in China supported rapid expansion of the ... continue to fuel growth in the coming years. ... Interventional Cardiology Devices 2010 report finds that ... the Chinese drug-eluting stent market to reach a ...
(Date:12/16/2009)... Dec. 16 /PRNewswire/ -- Sanofi ... Group, announced today that it has entered ... Syntiron to develop and commercialize its prophylactic ... Staphylococcus aureus or MRSA. MRSA ... humans, sometimes referred to as multidrug-resistant ...
Breaking Medicine Technology:Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3Exposure to lead tobacco smoke raises risk of ADHD 10856 1Exposure to lead tobacco smoke raises risk of ADHD 10856 2Measuring and modeling blood flow in malaria 61892 1Measuring and modeling blood flow in malaria 61892 2
(Date:12/16/2009)... 16 New research published online, ... in pistachios, and molecules present in pistachios, ... decreases levels of an inflammatory marker known ... 2). Inflammation is a complex biological response ... irritants, and it underlies functional changes associated ...
(Date:12/16/2009)... The DNA of a 1st century shrouded man found in ... Jerusalem has revealed the earliest proven case of leprosy. Details ... PloS ONE Journal. , The molecular investigation was ... of the Sanford F. Kuvin Center for the Study of ... Prof. Carney Matheson and Ms. Kim Vernon of Lakehead University, ...
(Date:12/16/2009)... happens when the families of sick and dying hospitalized ... for them? How do pediatricians respond to such personal ... and spirituality help some patients and families cope with ... almost always the families and patients who raise the ... the current issue of Southern Medical Journal , ...
(Date:12/16/2009)... national AAD program ,, SCHAUMBURG, Ill., ... melanoma, the deadliest form of skin cancer, almost ... if caught early. That,s why thousands of dermatologists ... in their communities through the American Academy of ... program recently reached a milestone - two million ...
(Date:12/16/2009)... 16 Medizone International, Inc. (OTC Bulletin ... of Directors and the Board of Medizone New ... International Inc. holds a 50% interest, agreed on ... and reconvey to Medizone International all global marketing ... International,s Chairman, Edwin G. Marshall said, "Time has ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 2Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 3Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3Health News:Prayer on the hospital floor 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2
... slightly elevated chance of bladder, colorectal and lung malignancies ... external beam radiation for localized prostate cancer may have ... report. , The findings could have implications for men ... prostate cancer, the researchers said. , "We saw an ...
... Dynamic contrast-enhanced MRI (DCE-MRI) plus diffusion weighted imaging ... cancer in patients treated with high-intensity focused ultrasonic ... included 27 patients who had increased levels of ... focused ultrasonic (HIFU) ablation; 18 of these patients ...
... Forest University have uncovered evidence that the abnormal editing of ... be behind the development of lupus. Scientists hope the finding ... response to therapy and possibly a new way to treat ... Immunology, involve an enzyme that edits and modifies the messages ...
... Netherlands, May 19 At the "World Aquaculture,2008", ... Dr. George Gettinby from,the University of Strathclyde, Scotland, ... Award for his innovative statistical and,epidemiological research methods ... his research methods an excellent example of commitment ...
... Saves money and time spent in intensive care units, ... Endotracheal tubes coated with silver dramatically reduce infections from ... ventilators breathe through a tube placed through their trachea ... for developing what is called ventilator-associated pneumonia. , "Ventilator-associated ...
... 19 Murad, Inc. announced today,the appointment of ... of,International Business for Latin America. In this position, ... brand,s presence in key,areas, identify prospective partners and ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080519/LAM066 ), "Fernando joins the ...
Other Medicine News:Health News:Radiation for Prostate Cancer Raises Risk of Other Cancers 2Health News:Radiation for Prostate Cancer Raises Risk of Other Cancers 3Health News:Abnormal 'editing' of gene messages may be a cause of lupus 2Health News:Prof. Dr. George Gettinby Honored With Dieter Lutticken Award 2Health News:Prof. Dr. George Gettinby Honored With Dieter Lutticken Award 3Health News:Silver-Coated Endotracheal Tubes Cut Down on Infections 2Health News:Silver-Coated Endotracheal Tubes Cut Down on Infections 3Health News:Murad, Inc., Appoints Fernando Braga, Jr. as Director of International Business for Latin America 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: